search
Back to results

Disease Management in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Patients (ACDM-Maccabi)

Primary Purpose

Chronic Obstructive Pulmonary Disease (COPD), Asthma

Status
Terminated
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Pulmonary disease management
Usual care
Sponsored by
Sheba Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Obstructive Pulmonary Disease (COPD) focused on measuring Chronic obstructive pulmonary disease (COPD), Asthma

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Men and women
  2. 40 years or older
  3. Having unstable COPD or Asthma

Exclusion Criteria:

  1. Significant LV dysfunction
  2. Other severe chronic morbidity compromising short-term survival
  3. Significant cognitive impairment or psychiatric disease
  4. Bedridden
  5. Homeless or no telephone connection

Sites / Locations

  • Maccabi Pulmonary Clinic
  • Maccabi Pulmonary Clinic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Disease Management

Unual care

Arm Description

Comprehensive care delivered by designated nurses and pulmonologists, in collaboration with the primary practitioners and other healthcare professionals in the community

Care delivered by the primary practitioner with the advice of a consultant pulmonologist

Outcomes

Primary Outcome Measures

Healthcare services utilization for acute exacerbations of pulmonary disease
The proportion of patients who, due to exacerbation of their COPD or asthma, have at least one out of hours visit to a "off-hour non-hospital based acute-care facilities", or a visit to a hospital emergency room, or a hospitalization within the two years of follow-up.

Secondary Outcome Measures

Quality of life
Health-related quality of life
Pulmonary function tests
Pulmonary function tests
Physical function
6-minutes walk test assessment
Depression
PHQ-9 Questionnaire

Full Information

First Posted
April 8, 2010
Last Updated
January 20, 2015
Sponsor
Sheba Medical Center
Collaborators
Maccabi Healthcare Services, Israel
search

1. Study Identification

Unique Protocol Identification Number
NCT01101126
Brief Title
Disease Management in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Patients
Acronym
ACDM-Maccabi
Official Title
Disease Management Program for Chronic Obstructive Pulmonary Diseases in Maccabi Health Services
Study Type
Interventional

2. Study Status

Record Verification Date
January 2015
Overall Recruitment Status
Terminated
Why Stopped
An excess of all-cause acute health services utilization in the intervention arm
Study Start Date
March 2010 (undefined)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
April 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sheba Medical Center
Collaborators
Maccabi Healthcare Services, Israel

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether disease management program is effective in preventing acute exacerbations in patients with unstable chronic obstructive pulmonary disease (COPD) or asthma.
Detailed Description
The aim of the present study is to test the efficacy of a comprehensive community disease management program in patients with unstable chronic obstructive pulmonary disease (COPD) or asthma. The intervention is delivered by designated nurses and pulmonologists, in collaboration with the primary practitioners and other healthcare professionals at the community, in the Jerusalem and the Lowland District of Maccabi Health Services in Israel. The main purpose is to evaluate the effect of the intervention on the use acute care and emergency health services for acute exacerbation of the lung disease. Secondary objectives include the evaluation of the effect of the intervention on quality of life, physical function, pulmonary function test, depression and all-cause mortality.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease (COPD), Asthma
Keywords
Chronic obstructive pulmonary disease (COPD), Asthma

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
492 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Disease Management
Arm Type
Experimental
Arm Description
Comprehensive care delivered by designated nurses and pulmonologists, in collaboration with the primary practitioners and other healthcare professionals in the community
Arm Title
Unual care
Arm Type
Active Comparator
Arm Description
Care delivered by the primary practitioner with the advice of a consultant pulmonologist
Intervention Type
Other
Intervention Name(s)
Pulmonary disease management
Intervention Description
Comprehensive pulmonary care including patient education of self-care, coordination of care, monitoring of patient adherence, providing advice in acute exacerbations
Intervention Type
Other
Intervention Name(s)
Usual care
Intervention Description
Pulmonary disease is managed by the primary practitioner and a consultant pulmonologist
Primary Outcome Measure Information:
Title
Healthcare services utilization for acute exacerbations of pulmonary disease
Description
The proportion of patients who, due to exacerbation of their COPD or asthma, have at least one out of hours visit to a "off-hour non-hospital based acute-care facilities", or a visit to a hospital emergency room, or a hospitalization within the two years of follow-up.
Time Frame
Every 6 months during 1-3 years' follow-up
Secondary Outcome Measure Information:
Title
Quality of life
Description
Health-related quality of life
Time Frame
Every 6 months during 1-3 years' follow-up
Title
Pulmonary function tests
Description
Pulmonary function tests
Time Frame
Every 6 months during 1-3 years' follow-up
Title
Physical function
Description
6-minutes walk test assessment
Time Frame
Every 6 months during 1-3 years' follow-up
Title
Depression
Description
PHQ-9 Questionnaire
Time Frame
Every 6 months during 1-3 years' follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women 40 years or older Having unstable COPD or Asthma Exclusion Criteria: Significant LV dysfunction Other severe chronic morbidity compromising short-term survival Significant cognitive impairment or psychiatric disease Bedridden Homeless or no telephone connection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Meir Raz, M.D.
Organizational Affiliation
Maccabi Healthcare Services, Israel
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ofra Kalter - Leibovici, M.D.
Organizational Affiliation
Sheba Medical Center
Official's Role
Study Director
Facility Information:
Facility Name
Maccabi Pulmonary Clinic
City
Bat-Yam
Country
Israel
Facility Name
Maccabi Pulmonary Clinic
City
Holon
Country
Israel

12. IPD Sharing Statement

Learn more about this trial

Disease Management in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Patients

We'll reach out to this number within 24 hrs